Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11952184Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#7,825
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Gabi Hanna as a PI. Multi-PI records show the full award amount for context.
- 2R44DK125219-03R44One Health Advancement of RABI-767 for the Management of Acute Pancreatitis$873.7Kaward amount
- 5R44CA281622-02R44Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment$723.2Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Gabi Hanna as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardLamassu Pharma Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7825
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions